Eastwood Bio-Medical Canada Inc.
Financial Statements (IFRS) · Amounts in CAD
Income Statement
Balance Sheet
Cash Flow
| Line Item | Q2 2025Apr 30, 2025 | Q1 2025Jan 31, 2025 | Q4 2024Oct 31, 2024 | Q3 2024Jul 31, 2024 |
|---|---|---|---|---|
| Total Revenue | 76,782 | 214,720 | 177,614 | 188,262 |
| Operating Revenue | 76,782 | 214,720 | 177,614 | 188,262 |
| Cost Of Revenue | 39,376 | 55,656 | 80,807 | 57,338 |
| Gross Profit | 37,406 | 159,064 | 96,807 | 130,924 |
| Selling General And Administration | 134,545 | 111,146 | 122,311 | 148,712 |
| General And Administrative Expense | 132,981 | 110,958 | 121,963 | 146,885 |
| Depreciation And Amortization In Income Statement | 0.00 | 44,963 | 27,636 | 26,635 |
| Other Operating Expenses | 58,447 | 43,144 | 85,292 | 56,841 |
| Operating Expense | 192,992 | 199,253 | 235,239 | 232,188 |
| Operating Income | -155,586 | -40,189 | -138,432 | -101,264 |
| EBIT | -155,586 | -40,189 | -150,316 | -101,264 |
| Interest Income | -- | -- | -- | 0.00 |
| Interest Income Non Operating | -- | -- | -- | 0.00 |
| Net Interest Income | -1,104 | -801.00 | -1,226 | -3,231 |
| Other Income Expense | -210.00 | -198.00 | -16,282 | -10,711 |
| Special Income Charges | 0.00 | 0.00 | -4,679 | 0.00 |
| Write Off | 0.00 | 0.00 | 4,679 | 0.00 |
| Gain On Sale Of Security | -210.00 | -198.00 | -11,603 | -10,711 |
| Pretax Income | -156,900 | -41,188 | -155,940 | -115,206 |
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing And Discontinued Operation | -156,900 | -41,188 | -155,944 | -115,206 |
| Net Income From Continuing Operation Net Minority Interest | -156,900 | -41,188 | -155,944 | -115,206 |
| Net Income Including Noncontrolling Interests | -156,900 | -41,188 | -155,940 | -115,206 |
| Net Income Common Stockholders | -156,900 | -41,188 | -155,944 | -115,206 |
| Net Income | -156,900 | -41,188 | -155,944 | -115,206 |
| EBITDA | -155,586 | 4,774 | -122,680 | -74,628 |
| Normalized EBITDA | -155,376 | 4,972 | -106,398 | -63,917 |
| Reconciled Depreciation | 0.00 | 44,963 | 27,636 | 26,636 |
| Basic EPS | -0.01 | -0.01 | -- | -0.01 |
| Diluted EPS | -0.01 | -0.01 | -- | -0.01 |
| Basic Average Shares | 68.9M | 68.9M | -- | 68.9M |
| Diluted Average Shares | 68.9M | 68.9M | -- | 68.9M |
| Total Unusual Items | -210.00 | -198.00 | -16,282 | -10,711 |
| Total Unusual Items Excluding Goodwill | -210.00 | -198.00 | -16,282 | -10,711 |
| Tax Rate For Calcs | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Income | -156,690 | -40,990 | -139,662 | -104,495 |
| Amortization | 0.00 | 44,963 | 27,636 | 26,635 |
| Amortization Of Intangibles Income Statement | 0.00 | 44,963 | 27,636 | 26,635 |
| Depreciation Amortization Depletion Income Statement | 0.00 | 44,963 | 27,636 | 26,635 |
| Diluted NI Availto Com Stockholders | -156,900 | -41,188 | -155,944 | -115,206 |
| Insurance And Claims | 15,720 | 18,278 | 16,441 | 17,657 |
| Net Income Continuous Operations | -156,900 | -41,188 | -155,940 | -115,206 |
| Net Non Operating Interest Income Expense | -1,104 | -801.00 | -1,226 | -3,231 |
| Other Gand A | 40,357 | 2,600 | 23,757 | 21,130 |
| Reconciled Cost Of Revenue | 39,376 | 55,656 | 80,807 | 57,337 |
| Salaries And Wages | 76,904 | 90,080 | 81,765 | 108,098 |
| Selling And Marketing Expense | 1,564 | 188.00 | 348.00 | 1,827 |
| Total Expenses | 232,368 | 254,909 | 316,046 | 289,526 |
| Total Other Finance Cost | 1,104 | 801.00 | -- | 3,231 |
| Line Item | Q2 2025Apr 30, 2025 | Q1 2025Jan 31, 2025 | Q4 2024Oct 31, 2024 | Q3 2024Jul 31, 2024 |
|---|---|---|---|---|
| Cash And Cash Equivalents | 18,960 | 8,624 | 0.00 | 13,015 |
| Cash Cash Equivalents And Short Term Investments | 18,960 | 8,624 | 0.00 | 13,015 |
| Cash Financial | 18,960 | 8,624 | 0.00 | 13,015 |
| Accounts Receivable | 30,194 | 8,852 | 42,883 | 37,450 |
| Receivables | 30,194 | 8,852 | 42,883 | 37,450 |
| Prepaid Assets | 797.00 | 797.00 | 797.00 | 22,730 |
| Current Assets | 49,951 | 18,273 | 43,680 | 73,195 |
| Gross PPE | 536,791 | 536,791 | 835,515 | 835,515 |
| Accumulated Depreciation | -351,141 | -351,141 | -604,902 | -577,266 |
| Net PPE | 185,650 | 185,650 | 230,613 | 258,249 |
| Total Non Current Assets | 185,650 | 185,650 | 230,613 | 258,249 |
| Total Assets | 235,602 | 203,923 | 274,293 | 331,444 |
| Current Debt | 80,148 | 82,743 | 79,608 | 64,996 |
| Current Debt And Capital Lease Obligation | 80,148 | 82,743 | 79,608 | 64,996 |
| Accounts Payable | 139,838 | 49,891 | 75,457 | 110,398 |
| Payables | 1.6M | 1.5M | 1.5M | 1.4M |
| Payables And Accrued Expenses | 1.6M | 1.5M | 1.5M | 1.4M |
| Current Deferred Revenue | 14,635 | 4,738 | 16,619 | 28,879 |
| Current Liabilities | 1.7M | 1.5M | 1.6M | 1.5M |
| Total Non Current Liabilities Net Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities Net Minority Interest | 1.7M | 1.5M | 1.6M | 1.5M |
| Common Stock | 4.7M | 4.7M | 4.7M | 4.7M |
| Capital Stock | 4.7M | 4.7M | 4.7M | 4.7M |
| Retained Earnings | -6.2M | -6.0M | -6.0M | -5.8M |
| Gains Losses Not Affecting Retained Earnings | 9,514 | 9,514 | 9,514 | 9,514 |
| Common Stock Equity | -1.5M | -1.3M | -1.3M | -1.1M |
| Stockholders Equity | -1.5M | -1.3M | -1.3M | -1.1M |
| Total Equity Gross Minority Interest | -1.5M | -1.3M | -1.3M | -1.1M |
| Total Capitalization | -1.5M | -1.3M | -1.3M | -1.1M |
| Net Tangible Assets | -1.5M | -1.3M | -1.3M | -1.1M |
| Tangible Book Value | -1.5M | -1.3M | -1.3M | -1.1M |
| Working Capital | -1.7M | -1.5M | -1.5M | -1.4M |
| Invested Capital | -1.4M | -1.3M | -1.2M | -1.1M |
| Total Debt | 80,148 | 82,743 | 79,608 | 64,996 |
| Net Debt | 61,188 | 74,119 | 79,608 | 51,981 |
| Share Issued | 68.9M | 68.9M | 68.9M | 68.9M |
| Ordinary Shares Number | 68.9M | 68.9M | 68.9M | 68.9M |
| Current Deferred Liabilities | 14,635 | 4,738 | 16,619 | 28,879 |
| Duefrom Related Parties Current | -- | -- | 0.00 | 0.00 |
| Dueto Related Parties Current | 1.5M | 1.4M | 1.4M | 1.3M |
| Leases | -- | -- | 515,625 | 298,724 |
| Line Of Credit | 20,148 | 22,743 | 19,608 | -- |
| Machinery Furniture Equipment | -- | -- | -- | 216,901 |
| Other Current Borrowings | 60,000 | 60,000 | 60,000 | 64,996 |
| Other Properties | 319,890 | 319,890 | 319,890 | 319,890 |
| Properties | 216,901 | 216,901 | 0.00 | 0.00 |
| Line Item | Q2 2025Apr 30, 2025 | Q1 2025Jan 31, 2025 | Q4 2024Oct 31, 2024 | Q3 2024Jul 31, 2024 |
|---|---|---|---|---|
| Operating Cash Flow | 12,931 | 4,102 | -7,872 | -17,581 |
| Cash Flow From Continuing Operating Activities | 20,709 | -3,676 | -7,872 | -17,581 |
| Depreciation And Amortization | 0.00 | 44,963 | 27,636 | 26,636 |
| Depreciation Amortization Depletion | 0.00 | 44,963 | 27,636 | 26,636 |
| Change In Working Capital | 177,608 | -7,451 | 128,479 | 62,095 |
| Change In Receivables | -21,342 | 34,032 | -5,432 | -3,653 |
| Change In Payables And Accrued Expense | 189,053 | -29,602 | -277,214 | 44,551 |
| Change In Payable | 189,053 | -29,602 | -- | 44,551 |
| Change In Other Working Capital | 9,897 | -11,881 | 361,393 | 21,052 |
| Other Non Cash Items | -- | 7,778 | -7,799 | 9,266 |
| Net Issuance Payments Of Debt | -2,595 | 4,522 | -6,531 | 22,406 |
| Financing Cash Flow | -2,595 | 4,522 | -6,531 | 22,406 |
| Cash Flow From Continuing Financing Activities | -2,595 | 4,522 | -6,531 | 22,406 |
| Changes In Cash | 10,336 | 8,624 | -14,403 | 4,825 |
| Beginning Cash Position | 8,624 | 0.00 | 13,015 | 8,190 |
| End Cash Position | 18,960 | 8,624 | -1,388 | 13,015 |
| Free Cash Flow | 12,931 | 4,102 | -7,872 | -17,581 |
| Amortization Cash Flow | 0.00 | 44,963 | -- | 26,636 |
| Amortization Of Intangibles | 0.00 | 44,963 | -- | 26,636 |
| Change In Account Payable | 89,947 | -26,954 | -- | -21,400 |
| Change In Prepaid Assets | 0.00 | 0.00 | 49,732 | 145.00 |
| Net Income From Continuing Operations | -156,899 | -41,188 | -155,944 | -115,578 |
| Net Short Term Debt Issuance | -- | 4,522 | -6,531 | -- |